Why Non-Pharma Marketers Should Care About the FDA Public Hearing on Drug Promotion & Social Media
Posted in Health Marketing, Pharmaceutical Marketing, Social Media on Sep 21st, 2009
Early last weekend, the news broke that the FDA is holding a public hearing to help it adapt its regulatory posture to account for the special characteristics of social and Web 2.0 technologies. Specifically the FDA states that it is:
“[E]valuating how the statutory provisions, regulations, and policies concerning advertising and promotional labeling should be applied [...]

